نتائج البحث

The prognostic value of quantitative analysis of CCL5 and collagen IV in luminal B (HER2-) subtype breast cancer by quantum-dot-based molecular imaging

• Authors : Yong-Yun Zhu; Juanjuan Li; Chuang Chen

Subjects: 0301 basic medicine; Chemokine; Receptor, ErbB-2

• Source: International Journal of Nanomedicine

تفاصيل العنوان

High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer

• Authors : Sabino De Placido; Vincenzo Bagnardi; Lucia Gelao ...

Subjects: Oncology; Receptor, ErbB-2; medicine.medical_treatment

تفاصيل العنوان

Intermittent Fasting in Breast Cancer: A Systematic Review and Critical Update of Available Studies.

• Authors : Anemoulis, Marios¹; Vlastos, Antonios¹; Kachtsidis, Vasileios¹

Subjects: *PREVENTION of drug side effects; *BIOMARKERS; *ONLINE information services

• Source: Nutrients. Feb2023, Vol. 15 Issue 3, p532. 15p.

تفاصيل العنوان

Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer

• Authors : Yinhua Liu; Xuening Duan; Shuang Zhang

Subjects: Adult; Pulmonary and Respiratory Medicine; Oncology

• Source: Thoracic Cancer, Vol 12, Iss 24, Pp 3396-3406 (2021)Thoracic Cancer

تفاصيل العنوان

Nab-Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide in Neoadjuvant Chemotherapy for Resectable Breast Cancer: A Phase II Trial

• Authors : Yasuhiko Sakata; Yukiko Kajiwara; Yuri Takamatsu

Subjects: Cancer Research; medicine.medical_specialty; Cyclophosphamide

• Source: World Journal of Oncology

تفاصيل العنوان

Intermittent Fasting in Breast Cancer: A Systematic Review and Critical Update of Available Studies

• Authors : Marios Anemoulis; Antonios Vlastos; Vasileios Kachtsidis

Subjects: intermittent fasting; breast cancer; quality of lifeagris

• Source: Nutrients; Volume 15; Issue 3; Pages: 532

تفاصيل العنوان

Male Breast Cancer in Dr. Hasan Sadikin General Hospital: A Serial Case

• Authors : Sari, Rantapina Kurnia; Maman Abdurrahman; Monty Priosodewo Soemitro

Subjects: Chemotherapy; Hormonal receptor positive; Male breast cancer

• Source: Bioscientia Medicina : Journal of Biomedicine and Translational Research; Vol. 7 No. 7 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research; 3445-3452 ; 2598-0580 ;

تفاصيل العنوان

Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?

• Authors : Sara Broggi; Andrei Fodor; Claudio Fiorino ...

Subjects: medicine.medical_specialty; Receptor, ErbB-2; Tumor bed boost

• Source: The Breast : Official Journal of the European Society of MastologyBreast, Vol 55, Iss, Pp 45-54 (2021)

تفاصيل العنوان

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

• Authors : Richard Iggo; Jean-Michel Picquenot; Denis Larsimont ...

Subjects: Oncology; Cancer Research; medicine.medical_specialty

• Source: British Journal of CancerBritish Journal of Cancer, Cancer Research UK, 2019, 120 (9), pp.913-921. ⟨10.1038/s41416-019-0420-y⟩Bonnefoi, H, MacGrogan, G, Poncet, C, Iggo, R, Pommeret,

تفاصيل العنوان

Therapeutic escalation – De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB)

• Authors : Pierre Azuar; P.-E. Colombo; Emile Daraï

Subjects: Oncology; Receptor, ErbB-2; medicine.medical_treatment

• Source: The Breast. 34:24-33

تفاصيل العنوان